Woreta TA, Van Natta ML, Lazo M et al (2022) Validation of the accuracy of the FAST score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms
Demonstrates adherence to U.S
Key Takeaways Tesamorelin targets belly fat specifically and reduces visceral fat by 20% in 26 weeks Ipamorelin offers gentler fat loss with fewer side effects and better long-term safety Both peptides boost natural growth hormone production but use different pathways Medical supervision is required for safe use of either peptide therapy What Are Growth Hormone-Releasing Peptides
Alven, S., Peter, S., Mbese, Z., & Aderibigbe, B
Research includes potential applications in energy, recovery, and metabolic health